Jan Mattsson
Chief Operating Officer, ALBIREO PHARMA, INC.
Companies
- ALBIREO PHARMA, INC.Chief Scientific Officer Sep 10, 2020 to Mar 2, 20231
- ALBIREO PHARMA, INC.Chief operating officer Nov 7, 2016 to Jan 23, 20202
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- ALBIREO PHARMA, INC.0 shares3Mar 2, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 2, 2023U 35,524 shares of ALBIREO PHARMA, INC.3
- Jan 23, 2023Sold 197 shares at $43.80 of ALBIREO PHARMA, INC.4
- Jan 19, 2023Granted 55,000 shares of ALBIREO PHARMA, INC.5
- Jan 19, 2023Granted 55,000 shares of ALBIREO PHARMA, INC.6
- Jan 19, 2023Sold 3,088 shares at $43.80 of ALBIREO PHARMA, INC.7
- Oct 24, 2022Sold 202 shares at $19.58 of ALBIREO PHARMA, INC.8
- Jul 22, 2022Sold 205 shares at $24.68 of ALBIREO PHARMA, INC.9
- Apr 22, 2022Sold 200 shares at $32.92 of ALBIREO PHARMA, INC.10
- Jan 24, 2022Sold 808 shares at $24.88 of ALBIREO PHARMA, INC.11
- Jan 18, 2022Granted 21,600 shares of ALBIREO PHARMA, INC.12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Jan 23, 2023
- 5SEC EDGARForm 4 filed Jan 27, 2023
- 6SEC EDGARForm 4 filed Jan 25, 2023
- 7SEC EDGARForm 4 filed Jan 20, 2023
- 8SEC EDGARForm 4 filed Oct 25, 2022
- 9SEC EDGARForm 4 filed Jul 25, 2022
- 10SEC EDGARForm 4 filed Apr 25, 2022
- 11SEC EDGARForm 4 filed Jan 25, 2022
- 12SEC EDGARForm 4 filed Jan 20, 2022